BSE Live
Jan 21, 16:01Prev. Close
4058.35
Open Price
4035.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 21, 15:59Prev. Close
4051.90
Open Price
4051.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4041.90 (21)
| Key Financial Ratios of Sanofi India (in Rs. Cr.) | Dec 14 | Dec 13 | Dec 12 | Dec 11 | Dec 10 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 114.46 | 115.14 | 76.71 | 83.01 | 100.19 | |
| Diluted EPS (Rs.) | 114.46 | 115.14 | 76.71 | 83.01 | 100.19 | |
| Cash EPS (Rs.) | 156.43 | 155.21 | 115.73 | 96.54 | 108.76 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 643.67 | 580.30 | 518.02 | 479.67 | 434.79 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 645.18 | 584.76 | 522.85 | 484.85 | 440.35 | |
| Dividend / Share(Rs.) | 45.00 | 45.00 | 33.00 | 33.00 | 55.00 | |
| Revenue from Operations/Share (Rs.) | 858.65 | 785.44 | 683.04 | 565.06 | 495.82 | |
| PBDIT/Share (Rs.) | 175.07 | 197.90 | 153.27 | 137.02 | 110.57 | |
| PBIT/Share (Rs.) | 133.10 | 157.84 | 114.25 | 123.49 | 102.00 | |
| PBT/Share (Rs.) | 161.80 | 168.68 | 113.64 | 123.31 | 100.74 | |
| Net Profit/Share (Rs.) | 114.46 | 115.15 | 76.71 | 83.01 | 100.19 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 20.38 | 25.19 | 22.43 | 24.24 | 22.29 | |
| PBIT Margin (%) | 15.50 | 20.09 | 16.72 | 21.85 | 20.57 | |
| PBT Margin (%) | 18.84 | 21.47 | 16.63 | 21.82 | 20.31 | |
| Net Profit Margin (%) | 13.33 | 14.66 | 11.23 | 14.69 | 20.20 | |
| Return on Networth / Equity (%) | 17.78 | 19.84 | 14.80 | 17.30 | 23.04 | |
| Return on Capital Employed (%) | 16.77 | 18.81 | 14.19 | 16.68 | 22.41 | |
| Return on Assets (%) | 11.83 | 14.37 | 10.82 | 12.72 | 16.20 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 88.77 | 98.05 | 96.42 | 86.60 | 80.19 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.93 | 2.18 | 2.14 | 1.87 | 3.08 | |
| Quick Ratio (X) | 1.20 | 1.39 | 1.44 | 1.16 | 2.47 | |
| Inventory Turnover Ratio (X) | 4.14 | 5.32 | 5.77 | 5.12 | 4.73 | |
| Dividend Payout Ratio (NP) (%) | 39.31 | 39.08 | 43.02 | 39.75 | 54.89 | |
| Dividend Payout Ratio (CP) (%) | 28.76 | 28.99 | 28.51 | 34.18 | 50.56 | |
| Earnings Retention Ratio (%) | 60.69 | 60.92 | 56.98 | 60.25 | 45.11 | |
| Cash Earnings Retention Ratio (%) | 71.24 | 71.01 | 71.49 | 65.82 | 49.44 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 7,806.76 | 6,097.64 | 4,846.40 | 5,109.42 | 3,834.58 | |
| EV/Net Operating Revenue (X) | 3.95 | 3.37 | 3.08 | 3.93 | 3.36 | |
| EV/EBITDA (X) | 19.36 | 13.38 | 13.73 | 16.19 | 15.06 | |
| MarketCap/Net Operating Revenue (X) | 4.18 | 3.52 | 3.35 | 4.11 | 3.93 | |
| Retention Ratios (%) | 60.68 | 60.91 | 56.97 | 60.24 | 45.10 | |
| Price/BV (X) | 5.58 | 4.76 | 4.42 | 4.84 | 4.48 | |
| Price/Net Operating Revenue | 4.18 | 3.52 | 3.35 | 4.11 | 3.93 | |
| Earnings Yield | 0.03 | 0.04 | 0.03 | 0.04 | 0.05 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y